News

PMLive2h

Gilead Sciences’ Biktarvy granted FDA approval for expanded HIV use

Gilead Sciences’ Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets) has been approved by the ...
PMLive2h

Trust and trends – proactive protection

Proactive protection This trend captures a universal human truth – when the world feels uncertain, we cling to what we can ...
PMLive2h

FDA approves Apellis’ Empaveli for two rare kidney diseases

The US Food and Drug Administration (FDA) has approved Apellis Pharmaceuticals’ Sobi-partnered Empaveli (pegcetacoplan) to ...